Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Market Cap	8.31B
Revenue (ttm)	2.00B
Net Income (ttm)	245.65M
Shares Out	570.43M
EPS (ttm)	0.44
PE Ratio	33.10
Forward PE	22.82
Dividend	0.21 (1.44%)
Ex-Dividend Date	n/a

Volume	4,182,331
Average Volume	2,944,299
Open	14.58
Previous Close	14.56
Day's Range	14.58 - 14.97
52-Week Range	13.95 - 28.27
Beta	0.65
RSI	39.69
Earnings Date	Jul 21, 2025

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,759
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688575

Financial Performance

In 2024, Shenzhen YHLO Biotech's revenue was 2.01 billion, a decrease of -2.02% compared to the previous year's 2.05 billion. Earnings were 301.53 million, a decrease of -15.06%.